These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 26708384

  • 1. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis.
    Takiguchi G, Nishita M, Kurita K, Kakeji Y, Minami Y.
    Cancer Sci; 2016 Mar; 107(3):290-7. PubMed ID: 26708384
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Autonomous and intercellular chemokine signaling elicited from mesenchymal stem cells regulates migration of undifferentiated gastric cancer cells.
    Okamoto D, Yamauchi N, Takiguchi G, Nishita M, Kakeji Y, Minami Y, Kamizaki K.
    Genes Cells; 2022 May; 27(5):368-375. PubMed ID: 35261108
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Wnt5a/Ror2 pathway is associated with determination of the differentiation fate of bone marrow mesenchymal stem cells in vascular calcification.
    Xin H, Xin F, Zhou S, Guan S.
    Int J Mol Med; 2013 Mar; 31(3):583-8. PubMed ID: 23337931
    [Abstract] [Full Text] [Related]

  • 6. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer.
    Deng L, Chen N, Li Y, Zheng H, Lei Q.
    Biochim Biophys Acta; 2010 Aug; 1806(1):42-9. PubMed ID: 20122997
    [Abstract] [Full Text] [Related]

  • 7. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M, Tamada K, Oneyama C, Okada M, Takumi T, Nishita M, Minami Y.
    Oncogene; 2009 Sep 10; 28(36):3197-208. PubMed ID: 19561643
    [Abstract] [Full Text] [Related]

  • 8. Wnt5a/Ror2 mediates temporomandibular joint subchondral bone remodeling.
    Yang T, Zhang J, Cao Y, Zhang M, Jing L, Jiao K, Yu S, Chang W, Chen D, Wang M.
    J Dent Res; 2015 Jun 10; 94(6):803-12. PubMed ID: 25749876
    [Abstract] [Full Text] [Related]

  • 9. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
    Meijer J, Ogink J, Kreike B, Nuyten D, de Visser KE, Roos E.
    Cancer Res; 2008 Jun 15; 68(12):4701-8. PubMed ID: 18559516
    [Abstract] [Full Text] [Related]

  • 10. Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K/BxN serum-induced arthritis.
    Isozaki T, Arbab AS, Haas CS, Amin MA, Arendt MD, Koch AE, Ruth JH.
    Arthritis Rheum; 2013 Jul 15; 65(7):1736-46. PubMed ID: 23633118
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human trophoblasts recruited T lymphocytes and monocytes into decidua by secretion of chemokine CXCL16 and interaction with CXCR6 in the first-trimester pregnancy.
    Huang Y, Zhu XY, Du MR, Li DJ.
    J Immunol; 2008 Feb 15; 180(4):2367-75. PubMed ID: 18250446
    [Abstract] [Full Text] [Related]

  • 13. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
    Yuan Y, Niu CC, Deng G, Li ZQ, Pan J, Zhao C, Yang ZL, Si WK.
    Int J Mol Med; 2011 Jan 15; 27(1):63-9. PubMed ID: 21069266
    [Abstract] [Full Text] [Related]

  • 14. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
    Guo L, Cui ZM, Zhang J, Huang Y.
    Chin J Cancer; 2011 May 15; 30(5):336-43. PubMed ID: 21527066
    [Abstract] [Full Text] [Related]

  • 15. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase.
    Liu Y, Rubin B, Bodine PV, Billiard J.
    J Cell Biochem; 2008 Oct 01; 105(2):497-502. PubMed ID: 18615587
    [Abstract] [Full Text] [Related]

  • 16. Human gingival fibroblasts express functional chemokine receptor CXCR6.
    Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T.
    Clin Exp Immunol; 2009 Jun 01; 156(3):413-8. PubMed ID: 19438592
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.